ABC PICU is a randomized clinical trial that will compare the clinical consequences of RBC storage duration in 1538 critically ill children. Laboratory and observational evidence points to serious concerns about the lack of safety and effectiveness of older RBCs, especially in more vulnerable populations. Physicians and institutions have been systematically transfusing fresh RBCs to some pediatric patients primarily because of beliefs that the use of fresh RBCs improve outcomes. Conversely, the standard practice of blood banks is to deliver the oldest RBC unit in order to decrease blood wastage. To provide much needed high quality evidence to answer the question "do RBCs of reduced storage duration improve outcomes?" The ABC PICU Trial will conduct a RCT comparing development of New or Progressive Multiple Organ Dysfunction Syndrome (NPMODS) in critically ill children transfused with either RBCs stored ≤ 7 days or standard issue RBCs (expected mean RBC storage duration of 17-21 days).
AnemiaRed blood cell transfusionsRed blood cell storage agePediatricsCritical Care
For people ages up to 15 years
Patients are considered eligible to participate in the trial if one of the following occur:
First RBC transfusion is requested within the first 7 days (168 hours) of ICU admission.
First RBC transfusion is requested for a patient in the Emergency Room, and the PICU team is involved with the clinical care of the patient, and the patient will definitively be transferred to the ICU.
Patient assessed pre-operatively and for whom ICU admission is planned post-operatively, and who is determined to definitively require a first RBC transfusion during surgery.
Eligible critically ill pediatric patients who have an expected length of stay after transfusion in the ICU> 24 hours based on the best judgment of the attending ICU staff.
Age at time of enrollment < 3 days from birth or has reached their 16th birthday.
Post-conception age < 36 weeks at time of enrollment
Documented RBC transfusion within the 28 days prior to fulfilling the eligibility criteria
Previously randomized in this study
Weight < 3.0 kg on ICU admission
Conscious objection or unwillingness to receive blood products
Not expected to survive beyond 24 hours, brain death or suspected brain death
Limitation or withdrawal of care decisions have been made
Enrollment in another randomized clinical trial which has not been approved for co-enrollment
Patients for whom autologous and/or directed donation RBCs will be provided
Patients for whom the treating physician routinely and systematically requests RBC ≤14 days of storage
Patients for whom there systematically exist RBC aliquoting policies that mandate the initial use of units stored ≤ 14 days (ex: Pedi-Pack).
On ECMO or plan to be immediately placed on ECMO at time of enrollment
Patient predicted or presumed to require a massive transfusion (> 40ml/kg of all blood components in a 24 hour period) according to treating physician judgment
Refusal by physician
Inability to obtain consent
Blood bank personnel experiences difficulties in securing blood products (difficult cross matches, rare blood groups and diseases like IgA deficiency)
Insufficient number of ABO type compatible RBC units available in the blood bank at randomization with a storage time ≤ 7 days (minimum 1 unit regardless of patient age)
All RBC units available for the patient are not leukocyte-reduced prior to storage
University of California, San Francisconot yet accepting patients San Francisco, California, 94143, United States
Children's Hospital Los Angelesaccepting new patients Los Angeles, California, 90027, United States
Children's Hospital of Orange Countyaccepting new patients Orange, California, 92868, United States